Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids

Luca Gabutti, Giorgia Bianchi, Davide Soldini, Claudio Marone, Michel Burnier, Luca Gabutti, Giorgia Bianchi, Davide Soldini, Claudio Marone, Michel Burnier

Abstract

Background: In a previous study we demonstrated that mild metabolic alkalosis resulting from standard bicarbonate haemodialysis induces hypotension. In this study, we have further investigated the changes in systemic haemodynamics induced by bicarbonate and calcium, using non-invasive procedures.

Methods: In a randomized controlled trial with a single-blind, crossover design, we sequentially changed the dialysate bicarbonate and calcium concentrations (between 26 and 35 mmol/l for bicarbonate and either 1.25 or 1.50 mmol/l for calcium). Twenty-one patients were enrolled for a total of 756 dialysis sessions. Systemic haemodynamics was evaluated using pulse wave analysers. Bioimpedance and BNP were used to compare the fluid status pattern.

Results: The haemodynamic parameters and the pre-dialysis BNP using either a high calcium or bicarbonate concentration were as follows: systolic blood pressure (+5.6 and -4.7 mmHg; P < 0.05 for both), stroke volume (+12.3 and +5.2 ml; P < 0.05 and ns), peripheral resistances (-190 and -171 dyne s cm(-5); P < 0.05 for both), central augmentation index (+1.1% and -2.9%; ns and P < 0.05) and BNP (-5 and -170 ng/l; ns and P < 0.05). The need of staff intervention was similar in all modalities.

Conclusions: Both high bicarbonate and calcium concentrations in the dialysate improve the haemodynamic pattern during dialysis. Bicarbonate reduces arterial stiffness and ameliorates the heart tolerance for volume overload in the interdialytic phase, whereas calcium directly increases stroke volume. The slight hypotensive effect of alkalaemia should motivate a probative reduction of bicarbonate concentration in dialysis fluid for haemodynamic reasons, only in the event of failure of classical tools to prevent intradialytic hypotension.

Figures

Fig. 1
Fig. 1
Study design. Schematic representation of the study design.
Fig. 2
Fig. 2
Analysis of the haemodynamic parameter fluctuations. Schematic representation of the method used to calculate the maximum increase and decrease of each measured parameter during the dialysis session.
Fig. 3
Fig. 3
Panels A–D: Haemodynamic consequences of changing the calcium concentration in dialysis fluids. Systolic (Panel A) and diastolic (Panel B) pressure, stroke volume (Panel C) and peripheral resistance (Panel D) as a function of the haemodialysis time using a dialysate ionized calcium concentration of 1.25 (black squares) and 1.50 (empty squares) mmol/l, respectively. The mean differences between the curves and the statistical significances are superimposed in the figures.
Fig. 4
Fig. 4
Panels A–D: haemodynamic consequences of changing the bicarbonate concentration in dialysis fluids. Systolic (Panel A) and diastolic (Panel B) pressure, stroke volume (Panel C) and peripheral resistance (Panel D) as a function of the haemodialysis time using a high (empty diamonds) and a low (black diamonds) bicarbonate concentration in the dialysis fluid, respectively. The mean differences between the curves and the statistical significances are superimposed in the figures.

References

    1. Oettinger CW, Oliver JC. Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate. J Am Soc Nephrol. 1993;3:1804–1807.
    1. Rault R. Optimal dialysate bicarbonate during hemodialysis. ASAIO Trans. 1991;37:M372–M373.
    1. Kraut JA, Mishler DR, Singer FR, et al. The effects of metabolic acidosis on bone formation and bone resorption in the rat. Kidney Int. 1986;30:694–700.
    1. Cochran M, Wilkinson R. Effect of correction of metabolic acidosis on bone mineralization rate in patients with renal osteomalacia. Nephron. 1975;15:98–110.
    1. Movilli E, Zani R, Carli O, et al. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. Nephron. 2001;87:257–262.
    1. May RC, Kelly RA, Mitch WE. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J Clin Invest. 1987;79:1099–1103.
    1. Papadoyannakis NJ, Stefanidis CJ, McGeown M. The effect of correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nutr. 1984;40:623–627.
    1. Sethi D, Curtis JR, Topham DL, et al. Acute metabolic alkalosis during haemodialysis. Nephron. 1989;51:119–120.
    1. Kaye M, Somerville PJ, Lowe G, et al. Hypocalcemic tetany and metabolic alkalosis in a dialysis patient : an unusual event. Am J Kidney Dis. 1997;30:440–444.
    1. Arieff AI, Defronzo RA. Fluid, Electrolyte and Acid–Base Disorders. New York: Churchill Livingstone; 1995. Metabolic alkalosis; pp. 159–198.
    1. Streisand RL, Gourin A, Stuckey JH. Respiratory and metabolic alkalosis and myocardial contractility. J Thorac Cardiovasc Surg. 1971;62:431.
    1. Clancy RL, Cingolani HE, Taylor RR, et al. Influence of sodium bicarbonate on myocardial performance. Am J Physiol. 1967;212:917.
    1. Hernich WL, Hunt JM, Nixon JV. Increased ionized calcium and left ventricular contractility during hemodialysis. N Engl J Med. 1984;310:19–23.
    1. Kaye M, Vasilevsky M, Ketis M. The effect on blood pressure of an acute fall in ionized calcium during hemodialysis. A randomized study in two patients. Clin Nephrol. 1998;50:361–366.
    1. Van Der Sande FM, Cheriex EC, Van Kuijk WHM, et al. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients. Am J Kidney Dis. 1998;32:125–131.
    1. Leunissen KML, Van Den Berg BW, van Hooff JP. Ionized calcium plays a pivotal role in controlling blood pressure during haemodialysis. Blood Purif. 1989;7:233–239.
    1. Sherman RA, Bialy GB, Gazinski B, et al. The effect of dialysate calcium levels on blood pressure during hemodialysis. Am J Kidney Dis. 1986;8:244–247.
    1. Maynard JC, Cruz C, Kleerekoper M, et al. Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med. 1986;104:358–361.
    1. Gabutti L, Ross V, Duchini F, et al. Does Bicarbonate transfer have relevant hemodynamic consequences in standard hemodialysis? Blood Purif. 2005;23:365–372.
    1. Locatelli F, Covic A, Chazot C, et al. Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant. 2004;19:785–796.
    1. Graziani G, Casati S, Passerini P, et al. Pathophysiology and clinical consequences of metabolic alkalosis in hemodialyzed patients. Arch Ital Urol Nefrol Androl. 1987;59:105–111.
    1. Gabutti L, Ferrari N, Giudici G, et al. Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis. Nephrol Dial Transplant. 2003;18:2369–2376.
    1. Pederson KO. The effect of bicarbonate, PCO2 and pH on serum calcium fractions. Scand J Clin Lab Invest. 1971;27:145.
    1. Dolson GM, Ellis KJ, Bernardo MV, et al. Acute decreases in serum potassium augment blood pressure. Am J Kidney Dis. 1995;26:321–326.
    1. Sargent JA, Gotch FA. Principles and Biophysics of Dialysis. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, editors. Replacement of Renal Function by Dialysis. Vol. 2. Dordrecht, The Netherlands: Kluwer; 1996. pp. 74–76.
    1. Gabutti L, Marone C, Colucci G, et al. Citrate anticoagulation in continuous venovenous hemofiltration: a metabolic challenge. Intensive Care Med. 2002;28:1419–1425.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi